Loading...
Loading...
BVS| Name | Value |
|---|---|
| Revenues | 139.0M |
| Cost of Revenue | 45.4M |
| Gross Profit | 93.6M |
| Operating Expense | 84.9M |
| Operating I/L | 4.1M |
| Other Income/Expense | -8.9M |
| Interest Income | 0.0M |
| Pretax | -4.8M |
| Income Tax Expense | 0.6M |
| Net Income/Loss | -4.8M |
Bioventus Inc. is a medical device company that develops and commercializes clinical treatments to enhance the body's natural healing process. The company's product portfolio includes non-surgical joint pain injection therapies, peripheral nerve stimulation products, bone graft substitutes, ultrasonic medical devices for bone sculpting and tissue removal, ultrasonic bone healing system for fracture care, skin allografts, and advanced rehabilitation devices. Bioventus serves physicians in various orthopedic specialties, providing solutions for pain treatments, surgical procedures, and restorative therapies. The company generates revenue by selling these medical devices and treatments to physicians and healthcare facilities.
